To test this hypothesis, we introduced the STAT3 phosphorylation inhibitor Stattic into SLC9A2-knockdown tumor cells and observed that the upregulation of VEGFA induced by SLC9A2 knockdown was reversed (Fig. 6J). Here, SLC9A2 is linked to neoplasm.